8-K
filed April 14, 2026, 7:59 PM ET
ticker GCTK
CIK 0001506983
other material
confidence high
sentiment neutral
materiality 0.50
Glucotrack, Inc. (GCTK): debt financing — Glucotrack exchanges $600K promissory note for 895,000 common shares in debt-to-equity swap
Glucotrack, Inc.
- Partitioned $600K from $3.6M original note and exchanged it for 895K shares of common stock.
- Exchange done under Section 3(a)(9) exemption; no cash or other consideration paid by investor.
- Issuance subject to 19.9% beneficial ownership limitation; shares may be issued in tranches.
- Original note reduced by $600K, otherwise remains in full force.
- Holding period of original note (Sept 2025) tacks to exchange shares for Rule 144 purposes.
Key facts
Extracted from this filing and checked against the source text.
Debt Financings
SEC 8-K Item 2.03/2.04
confidence 0.9
Glucotrack, Inc. incurred loan of $600,000.
- Instrument
- loan
- Principal
- $600,000
- Event
- incurrence
Exact text from the filing
On April 13, 2026, Glucotrack, Inc. (the “Company”) entered into an Exchange Agreement (the “Exchange Agreement”) with an investor (the “Investor”) relating to an existing promissory note (the “Original Note”) previously issued to the Investor in the principal amount of $3,600,000. Pursuant to the Exchange Agreement, the Company and the Investor partitioned a new promissory note in the original principal amount of $600,000 (the “Partitioned Note”) from the Original Note.
View on SEC.gov
Equity Issuances
SEC 8-K Item 3.02/3.03
confidence 0.9
Glucotrack, Inc. issued 895,000 shares of common stock.
- Security
- common stock
- Shares
- 895,000 shares
Exact text from the filing
Under the Exchange Agreement, the Company and the Investor further agreed to exchange the Partitioned Note for an aggregate of 895,000 shares of the Company’s common stock, no par value per share (the “Exchange Shares”).
View on SEC.gov
Material Agreements
SEC 8-K Item 1.01/1.02
confidence 0.9
Glucotrack, Inc. entered into Exchange Agreement with an investor (the "Investor") (effective 2026-04-13).
- Action
- entry
- Counterparty
- an investor (the "Investor")
- Effective
- 2026-04-13
Exact text from the filing
On April 13, 2026, Glucotrack, Inc. (the “Company”) entered into an Exchange Agreement (the “Exchange Agreement”) with an investor (the “Investor”) relating to an existing promissory note (the “Original Note”) previously issued to the Investor in the principal amount of $3,600,000.
View on SEC.gov
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.